Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 inhibitors

Details for Australian Patent Application No. 2010300307 (hide)

Owner Cylene Pharmaceuticals, Inc.

Inventors Drygin, Denis; O'Brien, Sean; Anderes, Kenna; Vonhoff, Daniel D.; Lim, John K. C.; Padgett, Claire S.; Bliesath, Joshua R.; Ho, Caroline B.; Rice, William G.; Siddiqui-Jain, Adam

Agent Baldwins

Pub. Number AU-A-2010300307

PCT Pub. Number WO2011/041785

Priority 61/255,805 28.10.09 US; 61/323,771 13.04.10 US; 61/248,270 02.10.09 US; 61/380,685 07.09.10 US

Filing date 4 October 2010

Wipo publication date 7 April 2011

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/041785 Priority application(s): WO2011/041785

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010300317-System and method for block segmenting, identifying and indexing visual elements, and searching documents

2010300304-Migration-based illumination determination for AVA risk assessment